


395 F.3d 1364
United States Court of Appeals,
Federal Circuit.
MERCK & CO., INC., Plaintiff-Appellee,
v.
TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant.
No. 04-1005.
|
DECIDED: Jan. 28, 2005.
Synopsis
Background: Owner of patent for osteoporosis drug sued proposed manufacturer of generic version for infringement. The United States District Court for the District of Delaware, Joseph J. Farnan, Jr., J., 288 F.Supp.2d 601, held for owner, and competitor appealed.
 
Holdings: The Court of Appeals, Gajarsa, Circuit Judge, held that:
 
"about" 70/35 mg of alendronate monosodium trihydrate, called for in patent claims, meant approximately those amounts, and
 
patent was invalid as obvious.
 
Reversed.
 
Rader, Circuit Judge, dissented and filed opinion.
 
